IRWD FY 2023 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$629M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$443M+7.8% YoY

Gross Profit

$437M98.6% margin

Operating Income

-$945M-213.5% margin

Net Income

-$1.0B-226.4% margin

EPS (Diluted)

$-6.45

Cash Flow

Operating Cash Flow

$183M

Free Cash Flow

$183M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$471M

Total Liabilities

$817M

Stockholders' Equity

-$346M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$443M	$411M	+7.8%
Gross Profit	$437M	$409M	+6.7%
Operating Income	-$945M	$250M	-477.7%
Net Income	-$1.0B	$175M	-672.5%